Today: 27 April 2026
Stock market today: Dow futures steady as AI scare cools, Nvidia earnings and Trump tariffs loom

Stock market today: Dow futures steady as AI scare cools, Nvidia earnings and Trump tariffs loom

NEW YORK, Feb 25, 2026, 03:09 (EST)

Asian shares tracked higher Wednesday, with Japan’s Nikkei surging 2.2% to 58,583.12. U.S. stocks recovered from a tech slump, the S&P 500 adding 0.8% to 6,890.07, while the Dow tacked on 370 points to 49,174.50. Dow futures showed little movement as investors looked ahead to Nvidia’s results due after the bell.

This week’s moves have circled around a single question: are AI innovations going to juice profits, or wipe them out? Traders have been quick to dump shares exposed to automation — what’s being dubbed on some trading desks as the “AI scare trade,” triggered by anxiety that AI could cut into swathes of software and services revenue. Then, as headlines cooled, buyers snapped stocks right back. “It’s a relief rally after broad-based, indiscriminate selling,” said Ritesh Ganeriwal, head of investment at Syfe in Singapore. SWI swissinfo.ch

Chips and beaten-down software names drove Tuesday’s bounce on Wall Street, sending the Dow ahead 0.76%, the S&P 500 by 0.77%, and the Nasdaq 1.05% higher. Anthropic’s latest plug-in rollout gave a jolt to its partners—shares of U.S.-listed Thomson Reuters surged 11.5%, FactSet gained 5.9%, and Salesforce rose 4.1%. “It’s still early on in the process,” said Robert Pavlik, senior portfolio manager at Dakota Wealth. Reuters

Anthropic rolled out 10 fresh plug-ins aimed at enterprise users, just weeks after a legal-focused plug-in debut triggered a steep drop in software and services stocks. These new integrations—developed with help from partners such as LSEG, FactSet, Slack, and DocuSign—allow Claude AI to tap into tools like Gmail and Google Calendar. “It’s not a product that’s trying to own every workflow,” said Scott White, the company’s head of product for enterprise. Reuters

Advanced Micro Devices shares picked up ground after the company unveiled a five-year agreement to supply Meta Platforms with as much as $60 billion in AI chips. Nvidia, set to report earnings, also nudged higher, according to Reuters. “Yesterday’s reaction was so overdone that it can’t help but bounce a little bit,” said Ken Polcari, chief market strategist at Slatestone Wealth. Investing.com Australia

Trade policy remains out of sight. The U.S. started enforcing a temporary 10% tariff on global imports this Tuesday, though the Trump administration aims to bump that up to 15%, according to a White House official. “This is simple: the government unlawfully imposed a tax on Americans and took their money. We’d like it back,” said Sara Albrecht, chairman of the Liberty Justice Center. Reuters

Nvidia’s earnings are shaping up as the next major test, with investors eager for signs that the AI-driven surge in spending is translating into real earnings growth. Wall Street is looking for a profit spike of more than 62%, and revenue that could soar over 68% to $66.16 billion. That’s happening while AMD and Google, through Alphabet, keep rolling out their own AI chips and competing for TSMC’s manufacturing muscle, according to Reuters. “People are so concerned about AI spending — whether we’re in a bubble,” said Ivana Delevska, chief investment officer at Spear Invest. Reuters

Still, that calm might not last. If Nvidia trips up, tariffs shift again, or new supply-chain jitters flare, the so-called “AI scare trade” could resurface—quickly unraveling Tuesday’s bounce and exposing it as little more than a false start.

Aside from Nvidia, market eyes are on a five-year U.S. Treasury note auction and new central bank remarks set for this day. Traders also face fresh inflation figures out of Europe, Reuters’ “Trading Day” column reported. Reuters

Stock Market Today

  • Structure Therapeutics (GPCR) Valuation Falters Amid Share Price Decline
    April 26, 2026, 10:46 PM EDT. Structure Therapeutics (GPCR) shares dropped to $45.49, marking a 49.21% decline over 90 days despite a strong 91.62% one-year total return. The biotech's price-to-book (P/B) ratio of 2.1x appears undervalued versus peers' average of 31.2x and the US pharmaceuticals sector average of 2.6x, suggesting cautious investor sentiment. This ratio compares market value to book value, often used for early-stage or loss-making companies. GPCR faces risks from ongoing clinical trials for GSBR-1290 and significant net losses of $141.2 million. Analyst forecasts predict 56.5% annual revenue growth, but uncertainties linger. Investors should balance potential gains with risks, monitoring clinical outcomes and funding capabilities amid a volatile healthcare sector.

Latest article

Kratos Defense Stock Slides Again as Drone Maker’s $1 Billion Growth Bet Faces Test

Kratos Defense Stock Slides Again as Drone Maker’s $1 Billion Growth Bet Faces Test

26 April 2026
Kratos Defense shares dropped 6.5% to $61.26, cutting its market value to $10.6 billion as investors questioned the pace of profit from new contracts. The company recently completed the first flight of its Mk1 Firejet drone and won a Space Force contract worth up to $446.8 million. AeroVironment, L3Harris, and Northrop Grumman also declined. Kratos raised $1.17 billion in a February share offering.
Robinhood’s Earnings Week Now Has a Prediction-Market Problem

Robinhood’s Earnings Week Now Has a Prediction-Market Problem

26 April 2026
Wisconsin sued Robinhood and several rivals over sports event contracts, alleging illegal sports betting through prediction markets. The lawsuit comes days before Robinhood reports first-quarter earnings on Tuesday. Robinhood shares closed at $84.71 Friday, down from $91.28 on Monday. The company said its event contracts are federally regulated and it will defend itself.
SoFi Technologies Stock Faces a Big Q1 Earnings Test as Loan Growth Comes Into Focus

SoFi Technologies Stock Faces a Big Q1 Earnings Test as Loan Growth Comes Into Focus

26 April 2026
SoFi will report first-quarter results before markets open April 29, with management projecting about $1.04 billion in adjusted net revenue and adjusted EPS of 12 cents. Shares closed at $18.44 Friday, valuing the company at $23.8 billion. The company recently launched a digital HELOC and formed a Real Estate Advisory Council. Last quarter, loan originations rose 46% to $10.5 billion and fee-based revenue climbed 53%.
Singapore Airlines Q3 profit dives 69% despite record revenue as Air India losses weigh
Previous Story

Singapore Airlines Q3 profit dives 69% despite record revenue as Air India losses weigh

Centrica share price rises as British Gas owner locks in 10-year gas supply deal
Next Story

Centrica share price rises as British Gas owner locks in 10-year gas supply deal

Go toTop